SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acadia Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline – ACAD
NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Acadia Pharmaceuticals Inc. (Acadia or the Company)(NASDAQ: ACAD) and certain of its officers. The class action, filed in the United States…
